Julietta Korosteljova OÜ

Active Registry code 16697279 OÜ Tallinn Registered 16 Mar 2023
Compare

Julietta Korosteljova OÜ is a OÜ based in Tallinn, registry code 16697279, status: active. Main activity: Other human health activities n.e.c.. Its annual report for 2025 shows revenue of €3 288 and 0 employees.

Revenue
3 288 €
↑ 8.3% vs 2024
Employees
0
±0 vs 2024

2025 · annual report, e-Äriregister

Position in the industry Human health activities · EMTAK 86

  • Revenue · 2025 3 288 €
    industry median 20 811 € · companies in the industry: 3 373
  • Net profit margin · 2025 3.5 %
    industry median 8.3 % · companies in the industry: 2 759

Taxes and turnover

No tax data available. EMTA publishes data for those who paid state taxes, filed a VAT return or had employees in the quarter. New and small companies may be missing.

Financials by year

2023 – 2025
Revenue, € 2025: 3 288 € · +8.3% vs 2024 · industry median 20 811 € · above 29% of the industry
05 00010 00015 00020 00025 0002023 Company: 2 830 € Industry median: 19 469 €20232024 Company: 3 035 € Industry median: 20 000 €20242025 Company: 3 288 € Industry median: 20 811 €202505 00010 00015 00020 00025 0002023 Company: 2 830 € Industry median: 19 469 €20232024 Company: 3 035 € Industry median: 20 000 €2025 Company: 3 288 € Industry median: 20 811 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit, € 2025: 116 € · −30.5% vs 2024 · industry median 1 071 € · above 39% of the industry
05001 0001 5002 0002023 Company: 43 € Industry median: 1 745 €20232024 Company: 167 € Industry median: 1 621 €20242025 Company: 116 € Industry median: 1 071 €202505001 0001 5002 0002023 Company: 43 € Industry median: 1 745 €20232024 Company: 167 € Industry median: 1 621 €2025 Company: 116 € Industry median: 1 071 €2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Net profit margin, % 2025: 3.5 % · −2.0 pp vs the year before · industry median 8.3 % · above 38% of the industry
035810132023 Company: 1.5 % Industry median: 11.4 %20232024 Company: 5.5 % Industry median: 10.7 %20242025 Company: 3.5 % Industry median: 8.3 %2025035810132023 Company: 1.5 % Industry median: 11.4 %20232024 Company: 5.5 % Industry median: 10.7 %2025 Company: 3.5 % Industry median: 8.3 %2025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Assets, € 2025: 328 € · +43.9% vs 2024
01002003004002023 Company: 111 €20232024 Company: 228 €20242025 Company: 328 €202501002003004002023 Company: 111 €20232024 Company: 228 €2025 Company: 328 €2025
Equity, € 2025: 326 € · +55.2% vs 2024
01002003004002023 Company: 43 €20232024 Company: 210 €20242025 Company: 326 €202501002003004002023 Company: 43 €20232024 Company: 210 €2025 Company: 326 €2025
Employees 2025: 0 · industry median 2 · above 2% of the industry
0.00.51.01.52.02023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 220242025 Company: 0 Industry median: 220250.00.51.01.52.02023 Company: 0 Industry median: 220232024 Company: 0 Industry median: 22025 Company: 0 Industry median: 22025
  • Company
  • Industry median

Industry: Human health activities (the EMTAK division of the main activity). Median: half of the industry is above, half below.

Financials by year
Year Revenue, € Net profit, € Labour costs, € Assets, € Equity, € Employees
2025 3 288 116 0 328 326 0
2024 3 035 167 0 228 210 0
2023 2 830 43 0 111 43 0

Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.

Financial ratios for 2025

Net profit margin
3.5 %
Net profit / revenue
Return on equity (ROE)
35.6 %
Net profit / equity
Return on assets (ROA)
35.4 %
Net profit / assets
Equity ratio
99.4 %
Equity / assets
Debt ratio
0.6 %
Liabilities / assets
Current ratio
164.00
Current assets / current liabilities

Annual reports

PDFs from e-Äriregister
Annual reports
Year Period Filed Report Documents
2025 1 Jan 2025 – 31 Dec 2025 30 Apr 2026 Company’s own e-Äriregister
2024 1 Jan 2024 – 31 Dec 2024 30 Jun 2025 Company’s own e-Äriregister
2023 16 Mar 2023 – 31 Dec 2023 26 Jun 2024 Company’s own e-Äriregister

Board

Right of representation

Any member of the management board may represent the private limited company in all transactions.

Owners

Beneficial owners

Founders and other persons

Activities (EMTAK)

  • 86992Other human health activities n.e.c. Main
Rulings
Number, date Title Deadline State Document
Ä 50223313 / 4
28 Apr 2026
Amendment entry In force
28 Apr 2026
PDF
Ä 50223313 / M2
24 Apr 2026
Ruling to eliminate deficiencies 14 May 2026 Deficiencies eliminated
28 Apr 2026
PDF
Ä 50223313 / 3
25 Apr 2025
Amendment entry In force
25 Apr 2025
PDF
Ä 50223313 / 2
2 Sep 2023
Amendment entry In force
2 Sep 2023
PDF
Ä 50223313
16 Mar 2023
First entry In force
16 Mar 2023
PDF
Ä 50223313 / M1
7 Mar 2023
Ruling to eliminate deficiencies 22 Mar 2023 Deficiencies eliminated
16 Mar 2023
PDF

Sources: e-Äriregister and EMTA. Data updated 2 Nov 2026. Open at the source ↗ · Report an error in the data